Aro Biotherapeutics

0 followers


Unlocking the Potential of Genetic Medicines Based in Philadelphia, Aro Biotherapeutics is a biotechnology company pioneering the development of tissue-targeted genetic medicines with a platform based on a proprietary protein technology called Centyrins.

Industries

Headquarters

Stage

Employees

Links

Org chart

Susan Dillon
Co-Founder, President & CEO

Susan Dillon

Collapse
Mittie Doyle
Chief Medical Officer
Karyn O’Neil
Co-Founder & Chief Scientific Officer
Mark Laurenzi
Chief Administrative Officer & VP, Legal
Sukumar Sakamuri
Chief Technology Officer
Liz McKee Anderson
Independent Board Director, Chair Compensation Committee, Member, Audit Committee
Zhanna Druzina
Sr. Director
Jeffrey Staiger
SVP, Finance & Business Development